Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests meeting clinical needs (Q30449427)

21 June 2017

title

Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests meeting clinical needs (English)

1 reference

21 June 2017

1 reference

James C Boyd

1

1 reference

21 June 2017

David E Bruns

series ordinal

2

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

21 June 2017

published in

Methods in Enzymology

1 reference

21 June 2017

volume

467

1 reference

21 June 2017

page(s)

411-433

1 reference

Management of diabetes and hyperglycemia in hospitals

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Variability among five over-the-counter blood glucose monitors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Quality specifications based on analysis of effects of performance on clinical decision-making

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Tight glucose control in the intensive care unit: are glucose meters up to the task?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Intensive versus conventional glucose control in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Intensive insulin therapy in the medical ICU.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

Benefits and risks of tight glucose control in critically ill adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2809%2967016-6

7 January 2021

10.1016/S0076-6879(09)67016-6

Identifiers

DOI

1 reference

21 June 2017

1 reference